Leaders in Pharmaceutical Business Intelligence (LPBI) Group
www.pharmaceuticalintelligence.com2022 Update from LPBI Group. This article has five parts: Part 1: Web Site Statistics Part 2: 2.0 LPBI Group’s Four Missions: The Pipelines for 2021-2025 Part 3: Portfolio of IP Assets Part 4: Certificates – One Year Academic Internships in six Disciplines Part 5: Top 14 Articles by Views, All Time https://pharmaceuticalintelligence.com/2022/02/21/update-from-lpbi-group/ Portfolio of IP Assets https://pharmaceuticalintelligence.com/portfolio-of-ip-assets/ We Celebrate TEN Years of Excellence, LPBI Group: 4/2012 – 4/2022 https://pharmaceuticalintelligence.com/2022/04/25/we-celebrate-ten-years-of-excellence-lpbi-group-4-2012-4-2022/ Podcast about LPBI Group 2.0 LPBI is a Very Unique Organization https://pharmaceuticalintelligence.com/2021/03/02/2-0-lpbi-is-a-very-unique-organization/ Our Books: 18 volumes in Medicine - English Text https://lnkd.in/ekWGNqA Our Books: 18 volumes in Medicine - Spanish Audio https://pharmaceuticalintelligence.com/audio-english-spanish-biomed-e-series/ Our Team: https://pharmaceuticalintelligence.com/knowledge-portals-system-kps/ In 2021-2025 we are pursuing four missions: #1: 2021-2022 Medical Text Analysis (NLP) https://pharmaceuticalintelligence.com/2021-medical-text-analysis-nlp/ #2: Blockchain for Content Monetization https://pharmaceuticalintelligence.com/blockchain-transactions-network/ #3: New Genre of Scientific Books: Spanish Audio, Bi-lingual Spanish-English Text, NLP results of Text Analysis with machine learning, Editorial in audio #4: Drug design with Synthetic Biology Software https://pharmaceuticalintelligence.com/synthetic-biology-in-drug-discovery/ About our Journal http://pharmaceuticalintelligence.com NFT: Redefined Format of IP Assets https://pharmaceuticalintelligence.com/nft-redefined-format-of-ip-assets/
Read moreReach decision makers at Leaders in Pharmaceutical Business Intelligence (LPBI) Group
Free credit every month!
2022 Update from LPBI Group. This article has five parts: Part 1: Web Site Statistics Part 2: 2.0 LPBI Group’s Four Missions: The Pipelines for 2021-2025 Part 3: Portfolio of IP Assets Part 4: Certificates – One Year Academic Internships in six Disciplines Part 5: Top 14 Articles by Views, All Time https://pharmaceuticalintelligence.com/2022/02/21/update-from-lpbi-group/ Portfolio of IP Assets https://pharmaceuticalintelligence.com/portfolio-of-ip-assets/ We Celebrate TEN Years of Excellence, LPBI Group: 4/2012 – 4/2022 https://pharmaceuticalintelligence.com/2022/04/25/we-celebrate-ten-years-of-excellence-lpbi-group-4-2012-4-2022/ Podcast about LPBI Group 2.0 LPBI is a Very Unique Organization https://pharmaceuticalintelligence.com/2021/03/02/2-0-lpbi-is-a-very-unique-organization/ Our Books: 18 volumes in Medicine - English Text https://lnkd.in/ekWGNqA Our Books: 18 volumes in Medicine - Spanish Audio https://pharmaceuticalintelligence.com/audio-english-spanish-biomed-e-series/ Our Team: https://pharmaceuticalintelligence.com/knowledge-portals-system-kps/ In 2021-2025 we are pursuing four missions: #1: 2021-2022 Medical Text Analysis (NLP) https://pharmaceuticalintelligence.com/2021-medical-text-analysis-nlp/ #2: Blockchain for Content Monetization https://pharmaceuticalintelligence.com/blockchain-transactions-network/ #3: New Genre of Scientific Books: Spanish Audio, Bi-lingual Spanish-English Text, NLP results of Text Analysis with machine learning, Editorial in audio #4: Drug design with Synthetic Biology Software https://pharmaceuticalintelligence.com/synthetic-biology-in-drug-discovery/ About our Journal http://pharmaceuticalintelligence.com NFT: Redefined Format of IP Assets https://pharmaceuticalintelligence.com/nft-redefined-format-of-ip-assets/
Read moreCountry
State
Massachusetts
City (Headquarters)
Newton
Industry
Employees
11-50
Founded
2012
Social
Employees statistics
View all employeesPotential Decision Makers
Founder and Director of Pharmaceutical Business Intelligence Services
Email ****** @****.comPhone (***) ****-****Founder 2.0 Lpbi
Email ****** @****.comPhone (***) ****-****Director and Founder
Email ****** @****.comPhone (***) ****-****Founder 1.0 Lpbi and 2.0 Lpbi
Email ****** @****.comPhone (***) ****-****
Technologies
(4)